Elevated labile iron in castration–resistant prostate cancer is targetable with ferrous iron–activatable antiandrogen therapy
| Autor: | Gonciarz, Ryan L., Sakhamuri, Sasank, Hooshdaran, Nima, Kumar, Garima, Kim, Hyunjung, Evans, Michael J., Renslo, Adam R. |
|---|---|
| Zdroj: | In European Journal of Medicinal Chemistry 5 March 2023 249 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect